Screener/Healthcare/Biotechnology

TBPH

Theravance Biopharma, Inc.NASDAQ
$14.85+0.10 (+0.68%)
Small CapUnder $20Healthcare
$7.90
$21.03
$14.59
$14.97
EPS (TTM)$-0.51
P/E Ratio—
Dividend Yield—
Market Cap$705.6M
Volume399K
Prev Close$14.75
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$20.0M$3.6M$0.07—18.1%
Q2 '25—————
Q1 '25$15.4M-$13.6M$-0.27—-88.2%
Q4 '24$18.8M-$15.5M$-0.31—-82.8%
Q3 '24$16.9M-$12.7M$-0.26—-75.3%
Q2 '24$14.3M-$16.5M$-0.34—-115.9%
Q1 '24$14.5M-$11.7M$-0.24—-80.4%
Q4 '23$17.6M-$8.5M$-0.17—-48.4%
Get Your Daily Market Recap